Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month
Opioid-Induced Constipation Takes the Spotlight on TikTok
Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation Initiatives Aim to Spark Greater Awareness for These Conditions
LAVAL, QB, Dec. 3, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today introduced a collection of digital and social activations aimed at helping adult patients with opioid-induced constipation (OIC), irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Launched during Constipation Awareness Month in December, the digital and social activations are designed to help patients with constipation and their caregivers identify symptoms and potential causes of constipation and find appropriate treatment options.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8851251-salix-pharmaceuticals-bausch-health-constipation-awareness-month-resources/
"We understand the importance of reaching patients who may be suffering with various types of constipation where they are – in their homes and on their digital devices," said Robert Spurr, president, Salix Pharmaceuticals. "Our hope is that these new resources will help patients and their caregivers increase their understanding of the various types of constipation and potential underlying causes and may help them identify treatment options right for them."
OIC Takes the Spotlight on TikTok
To further share educational content about OIC and drive patients to visit UnderstandingOIC.com, Salix has partnered with five popular health care professionals on TikTok, including:
"I'm excited to collaborate with Salix to share information about OIC with my TikTok community," said Ethan Melillo. "It's important for people to understand they can lean on their pharmacist as a resource, especially when it comes to side effects of certain medications like opioids."
Since TikTok launched in 2016, it has continued to grow in popularity, including among the health care community. The innovative platform allows patients to interact and gain an understanding of specific topics from the comfort of their homes.
Jennifer Fijor agrees that social media allows health care providers and patients to break down the barriers often associated with discussing uncomfortable topics, like constipation. "I talk about lots of different types of constipation with my TikTok followers, because not all constipation is created equally," she said. "In my experience, most patients are unaware that their opioids could be causing their constipation. Through this partnership with Salix, I hope to bring awareness to OIC so that chronic pain patients on opioid therapy can get more information."
The TikTok campaign will continue throughout December and will be followed by other digital initiatives, including integrated audio content for voice-activated devices or speakers, which will offer listeners helpful information about OIC and tips on where to find more educational resources. Salix also illustrated patients' collective descriptions of living with OIC into a graphic depicting the patient experience to share with health care professionals and other patients to help visualize the shared story of several OIC patients. Edgy new banner ads were recently launched to capture the attention of web users seeking more information about this type of constipation.
IBS-C and CIC Initiatives Aim to Spark Greater Awareness
There is quantifiable evidence to show that people who have less than three bowel movements per week, hard to pass bowel movements, straining, discomfort and don't feel empty after a bowel movement, may be suffering from CIC.6 Add abdominal pain to those symptoms, and those people may have IBS-C.7
Proper diagnosis is not the only challenge. An online survey of individuals with IBS-C found that only 20 percent of respondents felt they were in control of their symptoms despite using a variety of treatments, and even fewer HCPs (6 percent) felt their patients were in control.8 Improved dialogue between HCPs and patients around IBS-C and CIC management pathway options is necessary to address unmet patient needs.
In addition to its educational website, ConfrontConstipation.com, Salix has distributed an informative article to regional and local news outlets across the country explaining the symptoms of IBS-C and CIC, as well as the potential underlying causes. The article also includes resources to encourage people experiencing constipation to have a productive conversation with their health care provider.
Salix has also partnered with a social influencer on Instagram to spark greater awareness and conversation about IBS-C and discuss a potential treatment option. By leveraging the voices of patients who reach a large and diverse audience, Salix hopes to motivate more individuals to seek diagnosis and relief.
Finally, to ensure that health care providers are kept updated about the urgency of addressing IBS-C and CIC, Salix is communicating directly with clinicians across the country to inform them of the latest perspectives of patients dealing with IBS-C and CIC.
About Bausch Health
©2021 Salix Pharmaceuticals or its affiliates.
View original content:https://www.prnewswire.com/news-releases/salix-brings-educational-resources-on-constipation-into-the-homes-of-patients-and-caregivers-for-constipation-awareness-month-301436763.html
SOURCE Bausch Health Companies Inc.
Keynote Presentation - Open to all Badge Holders
Keynote Panel Session - Open to all Badge Holders
#TECHSUPERSHOW Giveaways - Must be Present to Win!